Q2 FY2026 · ended Jun 30, 2026 · Revenue $1.53M, +27847.1% YoY · Filed Aug 14, 2026
Polomar Health Services, Inc. (PMHS) files with the SEC under industry code 2834, Pharmaceutical Preparations. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $1.5 million and net income of $200,358.
Revenue
$1.53M
+27847.1% vs year-ago quarter
Net income
$200,358
+133.1% vs year-ago quarter
Operating cash flow
$121,306
+164.6% vs year-ago quarter
Free cash flow
$-314,995
-4.0% vs prior quarter
EPS
$0.00
+100.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
28.38M
+1.6% vs year-ago quarter
Net cash
$81,832
Q1 FY2026
Operating margin
-295.0%
TTM
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMHS (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Palm Harbor, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1265521
- Former names
- Trustfeed Corp. (until Oct 11, 2024); HEALTHMED SERVICES LTD (until Apr 5, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.5M | $1.0M | $632,057 | $6,163 | $5,470 |
| Operating income | $218,377 | -$6,902 | -$8.9M | -$628,808 | -$563,333 |
| Net income | $200,358 | -$25,377 | -$9.0M | -$649,775 | -$605,563 |
| Diluted EPS | $0.00 | $0.00 | — | -$0.02 | -$0.02 |
| Operating cash flow | $121,306 | $34,376 | $190,021 | -$352,659 | -$187,780 |
| Total assets | $814,726 | $516,600 | $390,043 | $9.3M | $9.4M |
| Total liabilities | $1.9M | $1.8M | $1.6M | $1.5M | $1.0M |
| Stockholders' equity | -$1.1M | -$1.2M | -$1.2M | $7.8M | $8.4M |
| Cash and investments | $178,872 | $87,818 | $132,150 | $38,854 | $4,678 |
| Total debt | — | $5,986 | $14,864 | $23,620 | $32,257 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Restatement
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 19, 2026 | Oct 19, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Officer or director change, Bylaw or fiscal year change
|
Jul 30, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 20, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 17, 2026 | Jul 17, 2026 |
All 150 Polomar Health Services, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.